Navigation Links
Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN
Date:12/10/2009

The law firm of Hissey Kientz, LLP is warning all women using the birth control pills Yaz or Yasmin that they may face an increased risk of blood clots, heart attack, stroke, pulmonary embolism, deep vein thrombosis and other significant side effects as a result of the defective design of these products. In addition, one of the hormones in Yaz and Yasmin—known as drospirenone, or DRSP—has been linked to an increased risk of kidney injury or gallbladder problems.

(Vocus) December 10, 2009 -- The law firm of Hissey Kientz, LLP is warning all women using the birth control pills Yaz or Yasmin that they may face an increased risk of blood clots, heart attack, stroke, pulmonary embolism, deep vein thrombosis and other significant side effects as a result of the defective design of these products. Women taking Yaz and Yasmin are twice as likely to develop blood clots compared with other forms of birth control, according to two studies published in the British Medical Journal.

In addition, one of the hormones in Yaz and Yasmin—known as drospirenone, or DRSP—has been linked to an increased risk of kidney injury or gallbladder problems. DRSP is a diuretic—a chemical that helps to eliminate excess fluid from the body—and was added to Yaz and Yasmin in order to reduce bloating and weight gain during menstruation. However, DRSP can also cause unintended changes in the body’s chemistry that can lead to serious and potentially deadly health problems, including severe injury to the gallbladder requiring removal by invasive explant surgery.

“While DRSP was added to Yaz and Yasmin in order to limit the severity of menstrual symptoms, the results of doing so have been disastrous,” says attorney Kristin Giaquinta Schoen of Hissey Kientz, LLP. “Evidence suggests that DRSP causes an unnecessary risk of kidney or gallbladder problems. Many women who have taken Yaz or Yasmin have suffered serious kidney damage or required surgery to remove their gallbladder.”

Based on reports to the Food and Drug Administration of side effects among birth control pill users, women taking Yaz and Yasmin were significantly more likely to have suffered deep vein thrombosis, pulmonary embolisms, strokes, heart attacks, gallbladder problems or death compared with women taking a safer form of birth control pill, Ortho Tri-Cyclen.

In October 2008, the FDA forced the manufacturer of Yaz, Bayer Pharmaceuticals, to stop airing a series of advertisements which the agency said mislead women about the safety and health benefits of the drug. In a warning letter sent to the Bayer, the FDA said that these ads promoted the use of Yaz for conditions which it was never approved by the FDA to treat—such as serious acne or PMS—while downplaying the risk of serious side effects associated with the drug. The FDA later forced Bayer to air a series of advertisements to correct the misleading information the company provided to the public in the original commercials.

“In addition to selling a drug that had a significantly increased risk of stroke, pulmonary embolism, deep vein thrombosis, heart attack and death, Bayer shockingly promoted Yaz to women for conditions it was not approved to treat knowing full well that women using their product could face an increased risk of potentially fatal side effects,” says Schoen. “Many women were exposed to life-threatening health risks after they were prescribed Yaz solely to treat acne or PMS, despite the fact that there are safer and more effective drugs to treat these conditions. There is simply no reason why a woman should take birth control pills that could double her risk of blood clots to get rid of a few pimples.”

About Hissey Kientz, LLP
Hissey Kientz, LLP (http://www.hkllp.com) is currently accepting cases involving women who developed blood clots or other side effects after using the birth control pills Yaz, Yasmin or Ocella. Hissey Kientz, LLP also represents those other victims of mesothelioma and asbestos diseases, as well as those injured by a fentanyl or Duragesic overdose deaths, acute phosphate nephropathy as a result of a Fleet Phospho-soda bowel cleansing products, Digitek, Zicam, the Composix Kugel mesh patch, gadolinium MRI contrast dyes, Reglan, FELA railroad injury lawsuits, the Ortho Evra birth control patch, Fen-Phen products containing ephedra, as well as other defective drugs and devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call toll-free at (866) 275-4454.

###

Read the full story at http://www.prweb.com/releases/yaz-and-yasmin/side-effects-lawsuit/prweb3320084.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Hissey Kientz LLP Urges Patients To Heed FDA Warning About Phospho-soda Products
2. Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose
3. Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website
4. Supreme Court Ruling is a Victory for Consumers Injured by Dangerous Drugs, Says Hissey Kientz, LLP
5. Hissey Kientz, LLP Announces the Launch of Mesothelioma Lawyers Help Web Site
6. Hissey Kientz, LLP Warns Duragesic Patch Users About Potential Health Risks of Fentanyl Overdose
7. Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
8. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
9. Throw a Yellow Flag on Football-related Head Injuries, Warns the Harvard Mental Health Letter
10. Commentary warns of unexpected consequences of proton pump inhibitor use in reflux disease
11. FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN
(Date:5/30/2016)... , ... May 30, 2016 , ... ... businesses, announced today the publication of an original infographic, " Health Benefits Reimbursement ... insurance professionals understand how Zane Benefits complies with various federal regulations and reforms. ...
(Date:5/29/2016)... (PRWEB) , ... May 29, 2016 , ... Whole Health ... jaw clipper that has been available via Amazon.com. This new style of nail ... nails. , The jaw opening is approximately 4mm and the actual handle is 2.5mm ...
(Date:5/28/2016)... ... May 28, 2016 , ... SuperCloset is proud to officially launch our ... day issues, struggles and obstacles veterans’ need to overcome in order to face their ... or retired military veteran(s) with a donated SuperCloset product based on the needs and ...
(Date:5/28/2016)... CT (PRWEB) , ... May 28, 2016 , ... After a year and a half ... it was an extraordinary event. The Multiple Pathways of Recovery Conference was held May ... across the country and the United Kingdom came together to explore the many pathways individuals ...
(Date:5/27/2016)... ... ... Southland Log Homes , designer and manufacturer of America’s Favorite Log ... be found on its website at SouthlandLogHomes.com. , The designs of the wood ... craftsmanship of timber post and beam construction. The result is a barn that ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... Hutchison China MediTech (Chi-Med) ... the highly lucrative global oncology and immunology markets. ... first-in-class or best-in-class tyrosine kinase inhibitor (TKI) drugs, ... partners. HCM,s profitable Chinese healthcare business continues to ... progress of the mid-to-late-stage pipeline during 2016-17 (including ...
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
Breaking Medicine Technology: